255 related articles for article (PubMed ID: 34736172)
1. Simulation of magnetic nanoparticles crossing through a simplified blood-brain barrier model for Glioblastoma multiforme treatment.
Gkountas AA; Polychronopoulos ND; Sofiadis GN; Karvelas EG; Spyrou LA; Sarris IE
Comput Methods Programs Biomed; 2021 Nov; 212():106477. PubMed ID: 34736172
[TBL] [Abstract][Full Text] [Related]
2. Transmigration of magnetite nanoparticles across the blood-brain barrier in a rodent model: influence of external and alternating magnetic fields.
Gupta R; Chauhan A; Kaur T; Kuanr BK; Sharma D
Nanoscale; 2022 Dec; 14(47):17589-17606. PubMed ID: 36409463
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier crossing using magnetic stimulated nanoparticles.
Chen J; Yuan M; Madison CA; Eitan S; Wang Y
J Control Release; 2022 May; 345():557-571. PubMed ID: 35276300
[TBL] [Abstract][Full Text] [Related]
4. Optimal Magnetic Field for Crossing Super-Para-Magnetic Nanoparticles through the Brain Blood Barrier: A Computational Approach.
Pedram MZ; Shamloo A; Alasty A; Ghafar-Zadeh E
Biosensors (Basel); 2016 Jun; 6(2):25. PubMed ID: 27314396
[TBL] [Abstract][Full Text] [Related]
5. Magnetic targeting of nanoparticles across the intact blood-brain barrier.
Kong SD; Lee J; Ramachandran S; Eliceiri BP; Shubayev VI; Lal R; Jin S
J Control Release; 2012 Nov; 164(1):49-57. PubMed ID: 23063548
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues.
D'Agata F; Ruffinatti FA; Boschi S; Stura I; Rainero I; Abollino O; Cavalli R; Guiot C
Molecules; 2017 Dec; 23(1):. PubMed ID: 29267188
[TBL] [Abstract][Full Text] [Related]
7. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model.
Dilnawaz F; Singh A; Mewar S; Sharma U; Jagannathan NR; Sahoo SK
Biomaterials; 2012 Apr; 33(10):2936-51. PubMed ID: 22264522
[TBL] [Abstract][Full Text] [Related]
8. Guidance of Magnetic Nanocontainers for Treating Alzheimer's Disease Using an Electromagnetic, Targeted Drug-Delivery Actuator.
Do TD; Ul Amin F; Noh Y; Kim MO; Yoon J
J Biomed Nanotechnol; 2016 Mar; 12(3):569-74. PubMed ID: 27280254
[TBL] [Abstract][Full Text] [Related]
9. Modeling and simulation of crossing magnetic nanoparticles through blood brain barrier (BBB).
Pedram MZ; Shamloo A; GhafarZadeh E; Alasty A
Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():5280-3. PubMed ID: 25571185
[TBL] [Abstract][Full Text] [Related]
10. Remote control of the permeability of the blood-brain barrier by magnetic heating of nanoparticles: A proof of concept for brain drug delivery.
Tabatabaei SN; Girouard H; Carret AS; Martel S
J Control Release; 2015 May; 206():49-57. PubMed ID: 25724273
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
[TBL] [Abstract][Full Text] [Related]
12. Construction of doxorubicin-loading magnetic nanocarriers for assaying apoptosis of glioblastoma cells.
Wang X; Wang L; Tan X; Zhang H; Sun G
J Colloid Interface Sci; 2014 Dec; 436():267-75. PubMed ID: 25280371
[TBL] [Abstract][Full Text] [Related]
13. Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood-brain barrier.
Sun Z; Worden M; Wroczynskyj Y; Yathindranath V; van Lierop J; Hegmann T; Miller DW
Int J Nanomedicine; 2014; 9():3013-26. PubMed ID: 25018630
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
15. Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation.
Ding H; Sagar V; Agudelo M; Pilakka-Kanthikeel S; Atluri VS; Raymond A; Samikkannu T; Nair MP
Nanotechnology; 2014 Feb; 25(5):055101. PubMed ID: 24406534
[TBL] [Abstract][Full Text] [Related]
16. Movement of magnetic nanoparticles in brain tissue: mechanisms and impact on normal neuronal function.
Ramaswamy B; Kulkarni SD; Villar PS; Smith RS; Eberly C; Araneda RC; Depireux DA; Shapiro B
Nanomedicine; 2015 Oct; 11(7):1821-9. PubMed ID: 26115639
[TBL] [Abstract][Full Text] [Related]
17. Dynamic cerebral perfusion parameters and magnetic nanoparticle accumulation assessed by AC biosusceptometry.
Próspero AG; Soares GA; Moretto GM; Quini CC; Bakuzis AF; de Arruda Miranda JR
Biomed Tech (Berl); 2020 May; 65(3):343-351. PubMed ID: 31714878
[TBL] [Abstract][Full Text] [Related]
18. Computational Assessment of Unsteady Flow Effects on Magnetic Nanoparticle Targeting Efficiency in a Magnetic Stented Carotid Bifurcation Artery.
Hewlin RL; Smith M; Kizito JP
Cardiovasc Eng Technol; 2023 Oct; 14(5):694-712. PubMed ID: 37723333
[TBL] [Abstract][Full Text] [Related]
19. Computational modeling of magnetic nanoparticle targeting to stent surface under high gradient field.
Wang S; Zhou Y; Tan J; Xu J; Yang J; Liu Y
Comput Mech; 2014 Mar; 53(3):403-412. PubMed ID: 24653546
[TBL] [Abstract][Full Text] [Related]
20. Enhanced blood brain barrier permeability and glioblastoma cell targeting via thermoresponsive lipid nanoparticles.
Rehman M; Madni A; Shi D; Ihsan A; Tahir N; Chang KR; Javed I; Webster TJ
Nanoscale; 2017 Oct; 9(40):15434-15440. PubMed ID: 28976512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
